Among HER2 positive breast cancer, pegfilgrastim is also important for the completion of dose-dense AC (doxorubicin and cyclophosphamide) followed by P/T (paclitaxel/trastuzumab) [12]. Here, ERBB2 is linked to breast carcinoma.